Skip to content
StockMarketAgent
Direct answer
Synopsys operates as a dominant player in the consolidated EDA oligopoly. Secular tailwinds from increasing semiconductor complexity ensure mission-critical reliance on its software. However, a massive recent acquisition significantly boosts scale but temporarily pressures balance sheet health and operating margins. Fair value range: low $206, high $386, with mid-point at $294.
Stock analysis

SNPS fair value $206–$386

By StockMarketAgent.AI team· supervised by
Analizado: 2026-05-10Próxima actualización: 2026-08-10Methodology v2.5Review: automatedArchetype: Mature compounder
View archive
Precio
$516.48
▼ -222.88 (-43.15%)
Valor razonable
$294
$206–$386
Calificación
Vender
confidence 78/100
Potencial alcista
-43.1%
upside to fair value
Margen de seguridad
$249.56
MoS level · 15%
Capitalización bursátil
$98.9B
P/E fwd 30.3
Respaldo en inglésES
Mostrando la fuente en inglés mientras traducimos
Este informe aún no se ha traducido. Actualice en unos minutos una vez que la cola de traducción se ponga al día.

§1 Resumen ejecutivo

  • Current price of $516.48 ignores the fundamental risk introduced by $13.4B of fresh M&A debt.
  • Intrinsic models assign a mid-point of $293.61, heavily penalizing fading ROIC and integration risks.
  • A wide model spread exists, but even optimistic forward earnings models top out at $453.
  • The market is pricing in flawless execution and rapid deleveraging, offering zero margin of safety.
Fair value
$294
Margin of safety
-75.9%
Confidence
78/100
Moat
9/10

Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.

$516.48Price
Low $206.1
Mid $293.6
High $386.33

Synopsys operates as a dominant player in the consolidated EDA oligopoly. Secular tailwinds from increasing semiconductor complexity ensure mission-critical reliance on its software. However, a massive recent acquisition significantly boosts scale but temporarily pressures balance sheet health and operating margins.

  • High Switching Costs
    High Switching Costs
  • Intangible Assets
    Intangible Assets
  • Cycle upside
    Accelerating AI-driven chip designs and reshoring of fabs increase EDA software demand.

§2 Caso bajista

Under a recessionary stress test, top-line growth stalls to low single digits while the heavy fixed-cost base and massive $13.4B debt load decimate free cash flowFree cash flowOperating cash flow minus capital expenditures. The cash a business generates after maintaining and growing its asset base — the closest accounting proxy for owner-economics.. This combination leaves management unable to deleverage organically, forcing highly dilutive capital raises.

Cómo puede fallar esta tesis

M&A Integration Failure

· Medium

The recent transformative acquisition faces severe cultural and technical friction, causing delayed synergies and margin compression.

FV impact
-30%

Prolonged Semiconductor Cyclical Downturn

· Low

A severe pullback in global fab and R&D spending directly hits EDA tool renewals and seat expansions.

FV impact
-25%

Debt Servicing Crisis

· Low

The massive $13.4B debt load restricts operational flexibility amid rising interest rates, forcing dilutive equity raises or asset firesales.

FV impact
-40%
Señales de alerta temprana a vigilar
MétricaActualUmbral de activación
Operating margins fail to revert to the 25% historical baseline.MonitorDeterioration versus the report thesis
Net debt issuance accelerates instead of declining post-M&A.MonitorDeterioration versus the report thesis
Loss of market share to primary competitor Cadence.MonitorDeterioration versus the report thesis
Semiconductor capital expenditure guidance sharply revised downward.MonitorDeterioration versus the report thesis
Key engineering and executive talent departures post-acquisition.MonitorDeterioration versus the report thesis

§3 Historial financiero

Cuenta de resultados — últimos seis períodos

Concepto2021-10-312022-10-312023-10-312024-10-312025-10-31Trend
Ingresos$4.62B$5.32B+15.2%$6.13B+15.2%$7.05B+15.0%+11.2%
Beneficio bruto$3.72B$4.29B$4.88B$5.43B+9.9%
Beneficio operativo$1.16B$1.33B$1.36B$914.9M-5.8%
Beneficio neto$984.6M$1.23B+24.9%$2.26B+83.7%$1.33B-41.2%+7.9%
BPA (diluido)$4.81$6.29$7.92$14.51$8.04+13.7%
EBITDA$1.33B$1.56B$1.85B$2.50B+17.0%
I+D$1.59B$1.85B$2.08B$2.48B+11.7%
SG&A$956.3M$1.10B$1.43B$1.84B+17.8%

Puntuaciones de calidad

OCF / Beneficio neto
1.14×
>1 indica alta calidad de los beneficios
Umbral de calidad contable
Fail
Umbral ajustado por sector
ROIC
3.4%
Rentabilidad del capital invertido
Suscriptores individuales — desde §411 secciones más

Leer el análisis completo — 11 secciones más.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Informe completo para cada ticker cubierto
24 meses de archivo de calificaciones
Briefings de lista de seguimiento + alertas de cambio de calificación
Exportación PDF + DOCX en cualquier idioma
Comenzar prueba gratuita
Cancela cuando quieras.
CASH FLOW FAQ

SNPS cash flow questions

  1. Free cash flow for SNPS (SNPS) is computed as operating cash flow minus capital expenditure. We report both the absolute level and the FCF margin against revenue, with five years of trajectory.
FAQ

SNPS — frequently asked questions

  1. Based on our latest analysis, SNPS looks meaningfully overvalued. The current price is $516 versus a composite fair-value midpoint of $294 (range $206–$386), which implies roughly 43.1% downside to the midpoint.
Related coverage

Names readers of SNPS also follow

Same archetype: mature-compounder